CBLL1 and carcinoma: Given the important reported role of the E3 ubiquitin-ligase Hakai during carcinoma metastasis in vitro and in vivo, the development of novel inhibitors against the E3 ubiquitin-ligase Hakai appears to be an attractive strategy for therapeutic interventions.